Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
Zhang R, Tian L, Chen LJ, Xiao F, Hou JM, Zhao X, Li G, Yao B, Wen YJ, Li J, Zhang L, Chen XC, Luo F, Peng F, Jiang Y, Wei YQ.
Zhang R, et al. Among authors: luo f.
Gene Ther. 2006 Sep;13(17):1263-71. doi: 10.1038/sj.gt.3302756. Epub 2006 May 4.
Gene Ther. 2006.
PMID: 16672984